Landec(LFCR) - 2024 Q4 - Annual Results

Exhibit 99.1 Lifecore Biomedical Reports Fourth Quarter and Fiscal Year End 2024 Financial Results and Provides Corporate Update -- Recorded Revenues of $128.3 million for Fiscal 2024; Year-Over-Year Increase of 24.2% -- -- High Value Pipeline Continues to Advance Toward Commercialization -- -- State-of-the-Art Technology Enhancements to Expand Capacity and New Business Opportunities – Conference Call Tomorrow Morning at 8:30 a.m. ET CHASKA, Minn., August 26, 2024 -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ...